Myocardial Ischaemia National Audit Project

Myocardial Ischaemia National Audit Project
Name	Myocardial Ischaemia National Audit Project
Abbreviation	MINAP
Formation	1998
Type	Clinical audit
Headquarters	United Kingdom
Region served	England and Wales
Parent organization	National Health Service

Myocardial Ischaemia National Audit Project

The Myocardial Ischaemia National Audit Project is a national clinical audit that systematically collects, analyses, and reports data on acute coronary syndromes across hospitals in England and Wales. It supports quality improvement by benchmarking care against national standards, informing commissioners, regulators, and professional bodies. Key stakeholders include a range of healthcare providers, academic centres, royal colleges, and regulatory agencies.

Overview

MINAP functions as a comprehensive cardiac audit linking episodes of care for conditions such as myocardial infarction, acute coronary syndrome, and unstable angina across secondary care settings. It aggregates patient-level data to enable comparisons between organisations such as NHS Trusts, Foundation trusts, and specialist centres like Barts Health NHS Trust and Guy's and St Thomas' NHS Foundation Trust. Outputs inform guideline-producing bodies including the National Institute for Health and Care Excellence, the British Cardiovascular Society, and the Royal College of Physicians and are used by oversight organisations such as NHS England and the Care Quality Commission.

History and Development

MINAP was established in the late 1990s following policy initiatives from UK health authorities that mirrored international registries including the Global Registry of Acute Coronary Events and the Swedish Web-System for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies. Early development involved collaborations with academic centres like University College London and Imperial College London and stakeholder groups such as the British Heart Foundation and professional societies including the British Cardiovascular Intervention Society. Over time MINAP evolved alongside national programmes such as the Darzi Review and reforms in the National Health Service landscape, expanding datasets and reporting capabilities to reflect advances in reperfusion therapy, pharmacotherapy, and emergency care pathways.

Governance and Funding

Governance structures have combined clinical leadership from organisations like the Royal College of Nursing and the Royal College of Physicians with management by entities within the NHS Confederation and commissioning oversight by bodies such as NHS England and local Clinical Commissioning Groups. Funding streams historically included grants from the Department of Health and Social Care, charitable support from the British Heart Foundation, and budgetary allocations via national audit programmes administered by agencies such as Healthcare Quality Improvement Partnership. Data stewardship and legal frameworks intersect with legislation like the Data Protection Act 1998 and later regulations under the European Union's data directives and subsequent UK provisions.

Data Collection and Methodology

MINAP captures coded, patient-level records including demographic, clinical, process, and outcome variables collected at hospitals including cardiology departments at centres like Royal Brompton Hospital and Leeds General Infirmary. Data linkage strategies have incorporated mortality data from registries such as the Office for National Statistics and procedure data from national datasets including the Hospital Episode Statistics and the National Institute for Cardiovascular Outcomes Research. Methodological development drew on epidemiological expertise from universities like University of Oxford and University of Manchester and applied standards used by international registries such as the American College of Cardiology's registries. Quality assurance mechanisms include validation against local audit reviews, standardised case definitions, and risk-adjustment models derived from prognostic work associated with investigators at institutions like Addenbrooke's Hospital.

Performance Measures and Outcomes

Key performance indicators reported by MINAP encompass timely reperfusion metrics for percutaneous coronary intervention and thrombolysis, secondary prevention prescribing rates for agents such as aspirin, beta blockers, and statins, and in-hospital mortality and 30-day mortality outcomes. Reports enable benchmarking across organisations including multi-site trusts like King's College Hospital NHS Foundation Trust and inform performance frameworks used by NHS Improvement and the Care Quality Commission. Findings from MINAP analyses have paralleled evidence from landmark trials and registries that shaped clinical standards promoted by bodies like the European Society of Cardiology and the American Heart Association.

Impact on Clinical Practice and Policy

MINAP has influenced clinical pathways including the development of regional reperfusion networks, primary percutaneous coronary intervention hub-and-spoke models observed in regions served by trusts such as Liverpool University Hospitals NHS Foundation Trust and Manchester University NHS Foundation Trust. Its data have underpinned guideline updates by the National Institute for Health and Care Excellence and informed commissioning decisions by Clinical Commissioning Groups and NHS England programme leads. Academic outputs citing MINAP datasets have appeared in journals associated with organisations like The Lancet, British Medical Journal, and Heart, contributing to translational changes in care endorsed by the Royal Colleges and specialist societies.

Limitations and Criticisms

Critics have noted limitations common to administrative and clinical registries: potential for missing data, variability in coding between hospitals such as University Hospitals Birmingham NHS Foundation Trust and smaller district hospitals, and challenges in capturing out-of-hospital events and long-term outcomes beyond linkage to the Office for National Statistics. Concerns about representativeness, data completeness, and timeliness have been raised by academic groups at institutions like Queen Mary University of London and by policy analysts associated with think tanks and oversight bodies. Debates continue regarding the balance between detailed clinical granularity and feasibility, resource requirements highlighted by audits involving bodies such as the National Audit Office.

Category:Clinical audit in the United Kingdom